-
The Soft Science in Hard Decisions: Utility of Qualitative Evidence in HTA Decisions
Sep 9, 2025, 16:22 PM -
Health Economic Evaluation Model for Breast Cancer Risk Management Through Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)
Sep 9, 2025, 16:22 PM -
Healthcare and Economic Impact of Friedreich's Ataxia in Italy: A Stratified Analysis Based On Patients’ Ambulatory Status
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of High-Dose Trivalent Influenza Vaccine in the Elderly: A Cohort-Based Economic Model From the Italian NHS Perspective
Sep 9, 2025, 16:22 PM -
How Will Patient Registry Data Play a Role in Joint Clinical Assessment (JCA) for Rare Diseases Learnings From National Health Technology Assessments (HTAs)?
Sep 9, 2025, 16:22 PM -
Pharosight: A Shiny-Based Interactive Platform With LLM-Enhanced Analyses and Predictive Modeling for Real-World Prescription Data
Sep 9, 2025, 16:22 PM -
The Growing Role of Real-World Evidence (RWE) to Support Efficacy in EMA Oncology Approvals: Light at the End of the Tunnel
Sep 9, 2025, 16:22 PM -
The Intercept of Real-World Evidence (RWE) Health Equity and Health Technology Assessment (HTA): A Structured Literature Review of Health Policy and Methodological Guidance
Sep 9, 2025, 16:22 PM -
COVID-19 mRNA-1273 Vaccination in the UK: A Comparative Modeling Study of Alternative Eligibility Criteria
Sep 9, 2025, 16:22 PM -
Epidemiological Characteristics and Economic Burden of IgA Nephropathy—a Retrospective Study Using Multicenter Electronic Medical Records Data in China
Sep 9, 2025, 16:22 PM -
Individual Therapy or No Therapy at All: Impact of Patient Individual Therapies As ACT in the German AMNOG Process
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Iptacopan vs. C5 Inhibitors in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria Naïve to Complement Inhibitors in the Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
Hospital Systemic Treatment for HepatoCarcinoma: The HOSTHECA Study
Sep 9, 2025, 16:22 PM -
Saving Money Improving Outcomes: A Two-Year Cost-Utility Analysis of Emergency Department Care Models for Managing Persons Presenting With a Musculoskeletal Disorder
Sep 9, 2025, 16:22 PM -
Optimizing MASLD Diagnostic Protocols: A Microsimulation Analysis of Test Sensitivity Requirements
Sep 9, 2025, 16:22 PM -
Modeling Physician Prescribing Decisions Based on Patient Characteristics for Positioning of a Novel Treatment Entering a Well-Established Category
Sep 9, 2025, 16:22 PM -
Health Economic Evaluation Model for Ovarian Cancer Risk Management Through Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Etrasimod, Ozanimod, and Adalimumab Compared to Infliximab in Treatment-Naive Patients With Moderate to Severe Ulcerative Colitis
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis Of Migalastat Incorporation vs. Enzyme Replacement Therapies For Fabry Disease: Validation of a Cost-Assessment Tool In Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
Food and Health Literacy Among University Students: Sociodemographic Insights
Sep 9, 2025, 16:22 PM
